Sensitivity problems with rapid antigen tests are also helping the more accurate rapid molecular tests gain wider acceptance, manufacturers said.
Among Flatiron's assets is a database developed in collaboration with Foundation Medicine intended to help biopharma firms develop more effective cancer therapies.
The investment bank gave the company's stock an Outperform rating with a target price of $90 per share.
The test reduces hands-on time by enabling labs to simultaneously assess Factor II and Factor V gene mutations from a single patient sample, Roche said.
Within the centralized and point-of-care solutions business, integrated serum work area solutions drove growth with immunodiagnostics sales rising 13 percent.
A jury agreed that Ariosa's noninvasive prenatal test infringed several claims in two patents held by Illumina.
The test has been validated for use with the same full set of female urogenital specimens that are used with Cobas NT/NG testing, as well as for use with male urine.
Pharmaceutical giant Roche has entered into a collaboration with Syapse to widen access to precision oncology technology and services.
The partners aim to develop jointly-branded clinical decision support software for faster, more accurate, and more confident decision-making.
CNN reports that researchers have tied a new variant to opioid addiction risk.
Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.
An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.
In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.